1 2 3 
Monday, April 12, 2021

BioAlberta has joined the national call for more collaboration to create a better environment for the development of new vaccines, meds and other health technologies in Canada.

Wednesday, April 7, 2021

BioAlberta believes Alberta is positioned to play a key role in enhancing domestic biomanufacturing capacity in Canada.

Thursday, April 8, 2021

BioNeutra North America Inc has signed an agreement with Western Economic Diversification Canada (WD) to accelerate the company's plans to increase its capacity and enhance business development activities.

Friday, March 26, 2021

Foodbev magazine has named BioNeutra's popular sugar reduction product -- VitaFiber® IMO -- as a finalist in the World's Food Innovation Awards for 2021.

Monday, March 15, 2021

Project funded through CQDM Quantum Leap program with support from Merck and GlycoNet will exploit new drug development platform

Monday, March 8, 2021

Alberta's government is accepting proposals to understand and explore opportunities related to the province's vaccine capacity as part of a long-term strategy to enhance our vaccine manufacturing capabilities.

Thursday, February 25, 2021

BioNeutra Global Corporation-maker of VitaFiber® IMO-today announced the launch of a multi-phase research project funded by three of the nation's leading research organizations to aid in the development of new better-for-you 'gut health' products.

Friday, February 19, 2021

RJH Biosciences persues novel reagents for CRISPR and mRNA-based therapies

Thursday, January 21, 2021

Canadian Hospital Specialties will be the exclusive distributor of Ekobi® Embolization Microspheres in Canada.

Wednesday, January 13, 2021

48Hour Discovery Inc. (48HD) and Quantum Intelligence Corp. (QIC) announced today the establishment of a joint venture called Quantum Intelligence Discovery.

Monday, December 14, 2020

The Port of San Diego has approved a pilot project with FREDsense Technologies Corp. to develop a portable five-in-one field-testing sensor device to provide real-time metals analysis for stormwater monitoring.

Monday, November 16, 2020

FoodBev, today named VitaFiber® IMO, a healthy alternative to sugar, as the world's top beverage ingredient. VitaFiber and other award winners were announced at the 18th Annual World Beverage Innovation Awards in Nuremberg.

Tuesday, November 10, 2020

Edmonton-based companies MACH32 and Andau Medical bring to market an aerosol containment device to reduce risk of COVID-19 exposure for healthcare personnel and patients.

Friday, November 6, 2020

November 6, 2020: BioAlberta Submission to the House of Commons Standing Committee on Health (HESA).

Friday, November 6, 2020

RJH Biosciences selected from over 1800 applicant companies around the World

An American judging panel has chosen a Canadian fibre product as a finalist for the 2020 U.S 'Prebiotic Ingredient of the Year' award. NutraIngredients-USA, a world leading digital trade publication, has announced that VitaFiber™ IMO is a finalist.

The Networks of Centres of Excellence (NCE) recently announced its continued support in Canadian glycomics research with a three-year investment of $16.3 million through the Canadian Glycomics Network (GlycoNet).

Edmonton-based biotechnology company CanBiocin Inc. has acquired all of the assets of Denver, CO based Pure Cultures Inc. effective April 30, 2020.

48Hour Discovery Inc. announced it has initiated drug discovery projects for therapeutic targets related to COVID-19. They will use proprietary technology to rapidly develop peptide-based anti-viral compounds for treatment of those infected with COVID-19.

A number of natural health product producers, spirits licensees, licenced users and brewer licensees (excise licensees) have stepped forward in response to COVID-19 with an interest in temporarily expanding their operations to produce hand sanitizer.

The National Research Council Canada is offering life science companies the opportunity to register for two programs: NRC COVID-19 Challenge Program & NRC Industrial Research Assistance Program. Read additional details here.

OncoQuest announces publication of two reports Related to the company's lead investigational drug in frontline Ovarian Cancer

Edmonton-based Radient Technologies is pleased to enter into a three-way agreement with Allied and the Dhaliwal Group to manage the supply chain, manufacturing and sale of high quality CBD distillate and isolate.

1 2 3